Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Prat, Aleix, Saura, Cristina, Pascual, Tomás, Hernando, Cristina, Muñoz, Montserrat, Paré, Laia, González Farré, Blanca, Fernández, Pedro L, Galván, Patricia, Chic, Núria, González Farré, Xavier, Oliveira, Mafalda, Gil-Gil, Miguel, Arumi, Miriam, Ferrer, Neus, Montaño, Alvaro, Izarzugaza, Yann, Llombart-Cussac, Antonio, Bratos, Raquel, González Santiago, Santiago, Martínez, Eduardo, Hoyos, Sergio, Rojas, Beatriz, Virizuela, Juan Antonio, Ortega, Vanesa, López, Rafael, Céliz, Pamela, Ciruelos, Eva, Villagrasa, Patricia, Gavilá, Joaquín
Published in The lancet oncology (01.01.2020)
Published in The lancet oncology (01.01.2020)
Get full text
Journal Article
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
Jerusalem, Guy, Park, Yeon Hee, Yamashita, Toshinari, Hurvitz, Sara A, Modi, Shanu, Andre, Fabrice, Krop, Ian E, Gonzàlez Farré, Xavier, You, Benoit, Saura, Cristina, Kim, Sung-Bae, Osborne, Cynthia R, Murthy, Rashmi K, Gianni, Lorenzo, Takano, Toshimi, Liu, Yali, Cathcart, Jillian, Lee, Caleb, Perrin, Christophe
Published in Cancer discovery (02.12.2022)
Published in Cancer discovery (02.12.2022)
Get full text
Journal Article
Web Resource
When Is Sentinel Node Biopsy Indicated in High-Risk Ductal Carcinoma in situ? Four Hundred Sixty-Eight Cases from Three Institutions
Cortadellas, Tomás, Argacha, Paula, Acosta, Juan, Jurado, Judith, Peiró, Ricardo, Gomez, Margarita, Gonzalez-Farré, Xavier, Martinez, Milagros, Luna, Miguel, Peg, Vicente, Gil-Moreno, Antonio, Xiberta, Manel
Published in Breast care (Basel, Switzerland) (01.12.2021)
Published in Breast care (Basel, Switzerland) (01.12.2021)
Get full text
Journal Article
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy
Pascual, Tomás, Fernandez-Martinez, Aranzazu, Agrawal, Yash, Pfefferle, Adam D, Chic, Nuria, Brasó-Maristany, Fara, Gonzàlez-Farré, Blanca, Paré, Laia, Villacampa, Guillermo, Saura, Cristina, Hernando, Cristina, Muñoz, Montserrat, Galván, Patricia, Gonzàlez-Farré, Xavier, Oliveira, Mafalda, Gil-Gil, Miguel, Ciruelos, Eva, Villagrasa, Patricia, Gavilá, Joaquín, Prat, Aleix, Perou, Charles M
Published in NPJ breast cancer (06.03.2024)
Published in NPJ breast cancer (06.03.2024)
Get full text
Journal Article
The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy
Gámez-Pozo, Angelo, Pérez Carrión, Ramón M, Manso, Luis, Crespo, Carmen, Mendiola, Cesar, López-Vacas, Rocío, Berges-Soria, Julia, López, Isabel Álvarez, Margeli, Mireia, Calero, Juan L Bayo, Farre, Xavier González, Santaballa, Ana, Ciruelos, Eva M, Afonso, Ruth, Lao, Juan, Catalán, Gustavo, Gallego, José V Álvarez, López, José Miramón, Bofill, Francisco J Salvador, Borrego, Manuel Ruiz, Espinosa, Enrique, Vara, Juan A Fresno, Zamora, Pilar
Published in PloS one (20.10.2014)
Published in PloS one (20.10.2014)
Get full text
Journal Article
Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study
Llombart-Cussac, Antonio, Ramos, Manuel, Dalmau, Elsa, García-Saenz, José A, González-Farré, Xavier, Murillo, Laura, Calvo, Lourdes, Morales, Serafín, Carañana, Vicente, González, Ana, Fernández-Morales, Luis A, Moreno, Fernando, Casas, Mª Isabel, Angulo, Mª del Mar, Cámara, Mª Carmen, Garcia-Mace, Ana I, Carrasco, Eva, Jara-Sánchez, Carlos
Published in European journal of cancer (1990) (01.05.2016)
Published in European journal of cancer (1990) (01.05.2016)
Get full text
Journal Article
Abstract P1-18-34: Solti-1507 IPATHER - A phase Ib study of ipatasertib (IPAT) and dual anti-HER2 therapy with pertuzumab and trastuzumab (HP) in patients with HER2-positive (HER2+) advanced breast cancer (ABC) and a PIK3CA mutation (mut): Results from the first safety cohort
Oliveira, Mafalda, Ciruelos, Eva, Morales, Serafín, Gavilá, Joaquín, Quiroga, Vanesa, Vega, Estela, Bofill, Javier Salvador, Cortegoso, Alexandra, Henao, Fernando, Tolosa, Pablo, Canes, Jordi, Villagrasa, Patricia, Farré, Xavier Gonzalez, Pascual, Tomás, Saura, Cristina
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract OT-09-08: Solti-1502 aRIANNA: Targeting PAM50 HER2-enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative metastatic breast cancer
Oliveira, Mafalda, Pernas, Sonia, Margelí, Mireia, Blanch, Salvador, Adamo, Barbara, Bofill, Javier Salvador, Moreno, Diana, Gonzalez-Farré, Xavier, Rios, José, Perou, Charles M, Prat, Aleix, Pascual, Tomás, Ferrero-Cafiero, Juan M, Villagrasa, Patricia, Manso, Luis
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract OT-35-01: Solti-1507 A phase ib study of ipatasertib and anti-her2 therapy in her2-positive advanced breast cancer with pik3ca mutation (ipather)
Oliveira, Mafalda, Villagrasa, Patricia, Ciruelos, Eva, Gavilá, Joaquín, Cortegoso, Alexandra, Henao, Fernando, Vega, Estela, Bofill, Javier S., Quiroga, Vanesa, García-Estevez, Laura, Morales, Serafín, Tolosa, Pablo, Céliz, Pamela, Farré, Xavier Gonzalez, Saura, Cristina
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract OT-28-05: Solti-1718 NEREA trial: Neratinib in hormone receptor (HR)-positive/HER2-negative HER2-Enriched (HER2-E) advanced breast cancer (BC)
Saura, Cristina, Ciruelos, Eva, Vidal, Maria, Garrigós, Laia, Margelí, Mireia, Morales, Serafin, Gonzalez-Farré, Xavier, Bofill, Javier Salvador, Blancas, Isabel, Gasent, Joan M, López-Miranda, Elena, Godoy, Ana, Iglesias, Maria, Sánchez-Rovira, Pedro, Hernao, Fernando, Gallegos, Isabel, Pulido, Catarina, Alves, Sara, Branco, Diogo, Passos-Coelho, José, Escrivá-de-Romaní, Santiago, Ferrero-Cafiero, Juan M, Villagrasa, Patricia, Prat, Aleix
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Abstract PO3-05-06: Targeting PAM50 HER2-Enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer: results of the SOLTI-1502 ARIANNA trial
Oliveira, Mafalda, Pascual, Tomás, Pernas, Sonia, Margelí, Mireia, Blanch, Salvador, Adamo, Barbara, Bofill, Francisco Javier Salvador, Gonzalez-Farré, Xavier, Chillara, Samyukta, Galván, Patricia, Sanfeliu, Esther, Blasco, Paula, Sirenko, Valeria, Espinosa, Alejandra, Perou, Charles M, Prat, Aleix, Manso, Luis
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PO3-19-08: A phase 2 randomized pre-operative,window of opportunity trial investigating the effect of elacestrant with/without triptorelin in premenopausal patients with HR+/HER2- breast cancer – SOLTI-2104-PremiÈRe trial
Ezquerra, Meritxell Bellet, Hernando, Cristina, Tolosa, Pablo, Vidal, Maria, Fernández, Yolanda, González-Santiago, Santiago, Sanchez, Pilar, Cruz, Susana De La, Ortega, Vanesa, Gonzalez-Farré, Xavier, Bergamino, Milana, Espinosa, Alejandra, Pascual, Tomás
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PO3-14-07: Characterizing Immune Infiltration in Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer: A Comprehensive Translational Analysis from four SOLTI Clinical Trials
Seguí, Elia, Sanfeliu, Esther, Brasó-Maristany, Fara, González-Farré, Blanca, Salvador, Fernando, Angelats, Laura, Villanueva, Lorea, Espinosa, Alejandra, Galván, Patricia, Fernández, Esther, Gonzalez-Farré, Xavier, Escrivá-de-Romaní, Santiago, Chic, Núria, Ciruelos, Eva, Saura, Cristina, Manso, Luis, Oliveira, Mafalda, Tabernero, Josep, Prat, Aleix, Pascual, Tomás
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PO3-05-07: SOLTI-1718 NEREA Trial: Neratinib in hormone receptor (HR)-positive/HER2-negative HER2-enriched (HER2-E) advanced breast cancer (BC)
Ciruelos, Eva, Saura, Cristina, Gonzalez-Farré, Xavier, Bofill, Francisco Javier Salvador, Vidal, Maria, Blancas, Isabel, López-Miranda, Elena, Iglesias, Maria, Arumí, Míriam, Margelí, Mireia, Pulido, Catarina, Murillo, Serafin Morales, Henao, Fernando, Sanchez, Pilar, Alves, Sara, Ortiz, Ana Godoy, Coelho, José Passos, Escrivá-de-Romaní, Santiago, Espinosa, Alejandra, Pascual, Tomás, Prat, Aleix
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract PD11-04: PD11-04 Primary results of SOLTI-1503 PROMETEO phase 2 trial of Combination of Talimogene Laherparepvec (T-VEC) with Atezolizumab in patients with residual breast cancer after standard neoadjuvant multi-agent chemotherapy
Pascual, Tomás, Vidal, Maria, Cejalvo, Juan Miguel, Vega, Estela, Sanfeliu, Esther, Ganau, Sergi, Julve, Ana, Zamora, Esther, Miranda, Ignacio, Delgado, Ana, Bermejo, Begoña, de la Cruz-Merino, Luis, Juan, Manel, Galván, Patricia, Gonzalez-Farré, Xavier, Ferrero-Cafiero, Juan Manuel, Villagrasa, Patricia, Oliveira, Mafalda, Prat, Aleix
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PD13-01: PD13-01 Elacestrant in postmenopausal women with estrogen receptor positive and HER2-negative early breast cancer: primary efficacy and safety analysis of the preoperative, window of opportunity SOLTI-1905-ELIPSE trial
Vidal, Maria, Pascual, Tomás, Falato, Claudette, Sanchez-Bayona, Rodrigo, Muñoz, Montserrat, Cerbrecos, Isaac, Gonzalez-Farré, Xavier, Cortadellas, Tomás, Margelí, Mireia, Luna, Miguel Angel, Siso, Christian, Amillano, Kepa, Galván, Patricia, Salvador, Fernando, Espinosa, Alejandra, Paré, Laia, Sanfeliu, Esther, Prat, Aleix, Ezquerra, Meritxell Bellet
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PD17-07: Cell-Cycle Inhibition and Immune Microenvironment in HR+/HER2- Breast Cancer During and After preoperative ribociclib and letrozole vesus chemotherapy: A correlative analysis of the 1402-SOLTI/CORALLEEN phase 2 trial
Pascual, Tomás, Chic, Nuria, Fernandez-Martinez, Aranzazu, González-Farré, Blanca, Paré, Laia, Saura, Cristina, Hernando, Cristina, Muñoz, Montserrat, Arumí, Míriam, Galván, Patricia, Gonzalez-Farré, Xavier, Oliveira, Mafalda, Gil, Miguel Gil, Ciruelos, Eva, Villagrasa, Patricia, Gregori, Joaquin Gavila, Prat, Aleix, Perou, Charles M.
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract GS01-03: Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy: interim analysis of the ALEXANDRA/IMpassion030 phase 3 trial
Ignatiadis, Michail, Bailey, Andrew, McArthur, Heather, El-Abed, Sarra, de Azambuja, Evandro, Metzger, Otto, Chui, Steve, Dieterich, Max, Perretti, Thomas, Steger, Guenther, Jassem, Jacek, Lee, Soo Chin, Higgins, Michaela, Zarbá, José, Schmidt, Marcus, Gomez, Henry, Guerrero-Zotano, Angel, Moscetti, Luca, Chiu, Joanne Win Yang, DuFrane, Carter, Honvault, Vanessa, Altarcheh, Rosa, Molinero, Luciana, Ellingson, Andrew, Munzone, Elisabetta, Ben-Baruch, Noa Efrat, Bajetta, Emilio, Ohno, Shinji, Im, Seock-Ah, Werutsky, Gustavo, Gal-Yam, Einav, Gonzalez-Farré, Xavier, Tseng, Ling-Ming, Jacot, William, Gluz, Oleg, Shao, Zhimin, Shparyk, Yaroslav, Sinielnikov, Ivan, Anastasia, Zimina, Vasiliev, Aleksandr, Shearer-Kang, Esther, Winer, Eric, Martins-Branco, Diogo, Fielding, Shona, Cameron, David, Viale, Giuseppe, Saji, Shigehira, Gelber, Richard, Piccart, Martine
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article